Cargando…
Effect of expansion of human umbilical cord blood CD34 + cells on neurotrophic and angiogenic factor expression and function
The use of CD34 + cell-based therapies has largely been focused on haematological conditions. However, there is increasing evidence that umbilical cord blood (UCB) CD34 + -derived cells have neuroregenerative properties. Due to low cell numbers of CD34 + cells present in UCB, expansion is required t...
Autores principales: | Watt, Ashalyn P., Kirkland, Mark, Nekkanti, Lakshmi, Pham, Yen, McDonald, Courtney, Malhotra, Atul, Moeneclaey, Guy, Miller, Suzanne L., Jenkin, Graham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976778/ https://www.ncbi.nlm.nih.gov/pubmed/35106623 http://dx.doi.org/10.1007/s00441-022-03592-2 |
Ejemplares similares
-
Umbilical cord blood therapy to prevent progression of COVID-19 related pneumonia: a structured summary of a study protocol for a pilot randomised controlled trial
por: Malhotra, Atul, et al.
Publicado: (2020) -
Abstract 32 Expanded Umbilical Cord Blood CD34+ Cells Are Immunomodulatory in a Rat Model of Neonatal Brain Injury
por: Penny, Tayla, et al.
Publicado: (2023) -
Umbilical Cord Blood and Cord Tissue-Derived Cell Therapies for Neonatal Morbidities: Current Status and Future Challenges
por: Zhou, Lindsay, et al.
Publicado: (2022) -
Is Umbilical Cord Blood Therapy an Effective Treatment for Early Lung Injury in Growth Restriction?
por: Allison, Beth J., et al.
Publicado: (2020) -
Endothelial colony forming cell administration promotes neurovascular unit development in growth restricted and appropriately grown fetal lambs
por: Bell, Alexander, et al.
Publicado: (2023)